FDA Approval, Genetic Disease, Genetics and Hormones

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA Approval

Genetic Disease

Genetics

Hormones

Surrogate Endpoints: How to Choose the Best One for Your Rare Disease Trial

XTalks

SEPTEMBER 17, 2020

For the following 15 rare diseases, all prevalence (approximate), symptom, etiology and treatment information was taken from the National Organization for Rare Disorders’ (NORD) Rare Disease Database , unless a link to another source is provided. Cushing’s Disease. Acromegaly. Prevalence: 50 to 70 people per 1 million.

Trials

Trials Gene Hormones Clinical Trials

Key Trends in the Life Sciences to Look Forward to in 2022

XTalks

DECEMBER 22, 2021

RNA therapeutics hold promise as powerful treatments for diseases, including those that are genetic-based. They can provide continuous real-time monitoring of metabolites, bacteria, hormones, glucose and other elements in these fluids. RNA Therapeutics. The deal is worth $1.5 Prior to this, Lilly struck an agreement worth $1.25

Life Science

Life Science RNA Vaccination Vaccine

Clinical Research Informer

Surrogate Endpoints: How to Choose the Best One for Your Rare Disease Trial

Key Trends in the Life Sciences to Look Forward to in 2022

Stay Connected